This is a specific type of meningitis caused by a fungus called Cryptococcus. It often affects people with weakened immune systems, like those with HIV. Symptoms can develop slowly and include headache, confusion, and sensitivity to light. It requires specific antifungal treatment.
Every report comes from a Lived member, sent anonymously.
Have you tried Amphotericin B for Cryptococcal Meningitis?
Cryptococcal meningitis is a serious fungal infection of the meninges, the protective layers that cover the brain and spinal cord. It is caused by Cryptococcus, a yeast-like fungus, and it mainly affects people whose immune systems are weakened, most often by advanced HIV. Because the infection can also involve the brain itself, doctors sometimes call it cryptococcal meningoencephalitis. This form of meningitis usually develops slowly, over a few days to a few weeks. Headache is often the main symptom, sometimes with fever, nausea and vomiting, sensitivity to light, a stiff neck, or confusion and changes in behavior. The gradual start can make it easy to dismiss at first, but the infection can cause lasting brain damage, vision and hearing loss, and death, so early diagnosis and treatment matter.
Cryptococcus lives in the environment, including soil around the world, and people are infected by breathing it in. The fungus can then lie dormant for a long time. Meningitis usually develops when the immune system weakens and the infection reactivates, spreading through the bloodstream to the brain. It is not spread from person to person. The biggest risk factor is HIV that has badly damaged the immune system, shown by a low CD4 count (CD4 cells are the infection-fighting white blood cells that HIV destroys). Other people at higher risk include organ transplant recipients taking anti-rejection medicines, people on other drugs that suppress the immune system, and people with conditions such as leukemia, lymphoma, sarcoidosis or cirrhosis of the liver. Some cases occur in people with no known immune problem. A related species, Cryptococcus gattii, is more likely than the common species to infect apparently healthy people.
The central test is a lumbar puncture (spinal tap), in which a thin needle placed in the lower back collects a sample of the fluid that surrounds the brain and spinal cord. The lab looks for the fungus under a microscope, grows it in culture and tests for cryptococcal antigen, a substance the fungus sheds. A rapid antigen test on blood helps show whether the infection has spread through the body. During the spinal tap, doctors also measure the opening pressure, the pressure of the spinal fluid when the needle first enters. A reading of 20 centimeters of water or higher is considered raised. High pressure is linked with severe headache, vision and hearing loss and a higher risk of death, so this number shapes treatment from the start. Brain imaging, ideally MRI, looks for fluid buildup and cryptococcomas (fungal masses in the brain), and blood cultures and chest imaging check for infection elsewhere. Anyone diagnosed without a known reason for weakened immunity should be tested for HIV and have a CD4 count checked. For adults with HIV whose CD4 count is below 200 cells per cubic millimeter, a blood antigen screening test can find the infection before meningitis develops. When the screen is positive but a spinal tap shows no meningitis, treatment with fluconazole pills can stop the infection from reaching the brain.
Treatment starts in hospital, and most people stay for at least one to two weeks. The first phase, called induction, uses strong antifungal medicines to clear the fungus quickly, usually over about two weeks. The standard approach combines amphotericin B, given through a vein, with flucytosine, an antifungal taken by mouth four times a day; adding flucytosine improves survival compared with amphotericin B alone. The liposomal form of amphotericin B (AmBisome) is easier on the kidneys than the older form. For people with HIV, the World Health Organization now prefers a single large dose of liposomal amphotericin B combined with two weeks of flucytosine and high-dose fluconazole, which worked as well as the previous regimen and was better tolerated. Amphotericin B can cause fever, chills, nausea and kidney damage, so it requires close monitoring. After induction, fluconazole (Diflucan), an antifungal pill, continues at a higher dose for consolidation and then at a lower daily dose for maintenance. Maintenance is very effective at preventing the infection from coming back. In people with HIV, relapse becomes very unlikely after at least a year of antifungal treatment once HIV medicines have controlled the virus or restored the CD4 count. Controlling pressure around the brain is as important as the antifungal medicines. Doctors relieve raised pressure by draining spinal fluid through repeated lumbar punctures, sometimes daily, and some people need a temporary drain or a permanent shunt. For people with HIV, HIV treatment is usually started about 4 to 6 weeks after antifungal treatment begins rather than right away. Starting too early increases the risk of death and of immune reconstitution inflammatory syndrome (IRIS), a dangerous flare of inflammation as the recovering immune system reacts to the remaining fungus. For transplant recipients, anti-rejection medicines may be adjusted, but cutting them too sharply can trigger a similar reaction. During pregnancy, amphotericin B is the mainstay, and fluconazole and flucytosine are avoided where possible, particularly in the first trimester.
Cryptococcal meningitis is a serious illness, and outcomes depend heavily on a person's underlying health and access to the best medicines. In US hospital studies, roughly 10% to 13% of people died during their hospital stay. In parts of the world where treatment options are limited, a quarter or more die within 10 weeks. The first weeks, with frequent spinal taps and close monitoring, are usually the most critical. Recovery can be slow, and a substantial share of survivors live with lasting effects such as vision or hearing loss, brain damage or hydrocephalus (a buildup of fluid in the brain) that needs a shunt. Follow-up continues for months, with regular visits while on fluconazole and attention to interactions with other medicines. For people with HIV, the period from about 2 weeks to 3 months after starting HIV treatment needs particular watchfulness, because that is when IRIS typically appears. Taking maintenance medicine consistently matters: most relapses happen when treatment was too weak or stopped early.
If you have HIV with a CD4 count below 200, ask your clinician whether you have had a cryptococcal antigen screening test. If you have advanced HIV, an organ transplant or other immune-suppressing treatment, get seen the same day for a headache that persists or builds over days, especially with fever, nausea or sensitivity to light. During or after treatment, contact your care team right away about a returning or worsening headache, blurred or lost vision, or new symptoms after starting HIV medicines, since these can signal rising pressure, relapse or IRIS. Call 911 for confusion, hallucinations, a seizure, or a stiff neck with fever, because meningitis can quickly become life-threatening.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Cryptococcal Meningitis is like, what's helped you, or ask the community a question.